Skip to content

Maria Paola Castelli

3 papers in the library · 63 citations · publishing 2019-2023

Papers

Sort Most recent Most cited

Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring.

Brain, Behavior, and Immunity February 1, 2023 Michele Santoni, Claudia Sagheddu, V. Serra et al.

Prenatal infections can increase the risk of developing psychiatric disorders such as schizophrenia in the offspring, especially when combined with other postnatal insults. Here, we tested, in a rat model of prenatal immune challenge by the viral mimic polyriboinosinic-polyribocytidilic acid, whether maternal immune activation (MIA) affects the endocannabinoid system and...

Sex and Gender Differences in the Effects of Novel Psychoactive Substances.

Brain Sciences September 3, 2020 Liana Fattore, Matteo Marti, Rafaela Mostallino et al. 63 citations

Sex and gender deeply affect the subjective effects and pharmaco-toxicological responses to drugs. Men are more likely than women to use almost all types of illicit drugs and to present to emergency departments for serious or fatal intoxications. However, women are just as likely as men to develop substance use disorders, and may be more susceptible to craving and relapse. Clinical and...

DOI: 10.3390/brainsci10090606 (opens in new tab) Full text (opens in new tab) Nps Cannabinoids Cathinones New synthetic drugs +3

Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe.

Frontiers in Pharmacology 2019 Cristina Miliano, Matteo Marti, Nicholas Pintori et al.

4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), commonly called "N-Bomb," is a synthetic phenethylamine with psychedelic and entactogenic effects; it was available on the Internet both as a legal alternative to lysergic acid diethylamide (LSD) and as a surrogate of 3,4-methylenedioxy-methamphetamine (MDMA), but now it has been scheduled among controlled substances. 25I-NBOMe...